T2 Biosystems, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
T2 Biosystems, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q2 2024.
  • T2 Biosystems, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $612K, a 90.9% decline year-over-year.
  • T2 Biosystems, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$3.16M, a 1262% decline year-over-year.
  • T2 Biosystems, Inc. annual Nonoperating Income (Expense) for 2023 was -$413K, a 93.9% increase from 2022.
  • T2 Biosystems, Inc. annual Nonoperating Income (Expense) for 2022 was -$6.81M, a 8.6% decline from 2021.
  • T2 Biosystems, Inc. annual Nonoperating Income (Expense) for 2021 was -$6.27M, a 15.2% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$3.16M $612K -$6.09M -90.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.93M -$934K +$3.34M +78.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 -$413K -$1.02M -$442K -76.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $29K -$1.82M -$243K -15.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-15
Q2 2023 $272K $6.7M +$9.72M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$9.45M -$4.28M -$2.64M -161% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 -$6.81M -$579K +$1.29M +69% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$8.09M -$1.58M +$175K +10% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-15
Q2 2022 -$8.27M -$3.02M -$1.32M -77.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$6.95M -$1.64M -$680K -71% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 -$6.27M -$1.87M -$276K -17.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$5.99M -$1.75M -$1.13M -183% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$4.86M -$1.7M +$151K +8.18% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-16
Q1 2021 -$5.01M -$958K +$430K +31% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$5.44M -$1.59M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$619K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$1.85M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$1.39M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.